Crossref
Tirzepatide as compared with semaglutide for the treatment of obesity
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.15.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Aronne LJ und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
LJ, A., DB, H., Roux, C. L., W, H., BL, F., Valderas, E. G., S, D., CJ, L., LC, G., C, S., JP, D., & ST, I. (2025). Tirzepatide as compared with semaglutide for the treatment of obesity. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.15.10
Vancouver
LJ A, DB H, Roux CL, W H, BL F, Valderas EG, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.15.10
BibTeX
@article{LJ2025,
author = {LJ, Aronne and DB, Horn and Roux, CW le and W, Ho and BL, Falcon and Valderas, E Gomez and S, Das and CJ, Lee and LC, Glass and C, Senyucel and JP, Dunn and ST, Investigators},
title = {Tirzepatide as compared with semaglutide for the treatment of obesity},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.15.10}
}
EUVIMED